The global, regional, and national patterns of change in the burden of congenital birth defects, 1990-2021: an analysis of the global burden of disease study 2021 and forecast to 2040.
Bai Z, Han J, An J, Wang H, Du X, Yang Z, Mo X. · 2024
Read The global, regional, and national patterns of change in the burden of congenital birth defects, 1990-2021: an analysis of the global burden of disease study 2021 and forecast to 2040. by Bai Z, Han J, An J, Wang H, Du X, Yang Z, Mo X. (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc11474384.txt.
Introduction
Bai and colleagues track the global burden of congenital birth defects from 1990 to 2021 and forecast it to 2040 in this 2024 study. Congenital birth defects are conditions present at birth that strain health systems worldwide. Prior studies were geographically limited. This analysis uses the Global Burden of Disease 2021 data for four major defects.
The four are congenital heart defects, neural tube defects, digestive anomalies, and Down syndrome. Burden is measured in disability-adjusted life years, a combined count of years lost to early death and years lived with disability. Patterns are reported globally, regionally, and nationally, with emphasis on health inequalities. The authors aim to supply scientific evidence for better resource allocation. High-burden populations are singled out for focus. The forecast to 2040 extends the planning horizon.
Catalog record
| CREATOR | Bai Z, Han J, An J, Wang H, Du X, Yang Z, Mo X. |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 93 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
The global, regional, and national patterns of change in the burden of congenital birth defects, 1990–2021: an analysis of the global burden of disease study 2021 and forecast to 2040 By Zihao Bai, Jingru Han, Jia An, Hao Wang, Xueying Du, Zhaocong Yang, Xuming Mo Published in: eClinicalMedicine DOI: 10.1016/j.eclinm.2024.102873 ABSTRACT Summary Background Congenital birth defects (CBDs) present enormous challenges to global healthcare systems. These conditions severely impact patients' health and underscore issues related to socioeconomic development and healthcare accessibility and efficiency. Previous studies have been geographically limited and lacked comprehensive global analysis. This study provides global, regional, and national disability-adjusted life years (DALYs) data for four major congenital birth defects—congenital heart defects (CHD), neural tube defects (NTDs), digestive congenital anomalies (DCAs), and Down syndrome (DS) from 1990 to 2021, emphasizing health inequalities. The goal is to offer scientific evidence for optimizing resource allocation, focusing on high-burden populations, and reducing disease burden. Methods This study systematically evaluated the global, regional, and national burden of CBDs and their changes from 1990 to 2021 using the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021. To conduct a more focused analysis, four specific CBDs were selected: CHD, NTDs, DCAs, and DS. DALYs were used as the metric, combined with the sociodemographic index (SDI). Analyses included the slope index of inequality and concentration index to measure health inequalities, frontier analysis to estimate achievable outcomes based on development levels, decomposition analysis to identify drivers of disease burden changes, Joinpoint regression analysis to assess temporal trends, and the Bayesian age-period-cohort (BAPC) model to predict future disease burden trends. Findings Compared to 1990, the global burden of the CBDs in 2021 showed a downward trend. Males had a higher burden than females, with the highest burden observed in low-SDI regions. When examining CHD, NTDs, DCAs, and DS specifically, trends in burden changes varied across different CBDs at the global, regional, and national levels. Frontier analysis revealed potential for burden improvement in various countries and territories. Decomposition analysis highlighted differences in disease burden drivers across SDI regions, showing the greatest improvement observed in low-SDI regions. Joinpoint regression analysis indicated a downward trend in DALYs burden across SDI regions, and BAPC model predictions suggested that the burden of CBDs will continue to decline in the future. Interpretation CBDs pose a major challenge to global public health. Despite an overall decline in disease burden, health inequalities remain prominent, particularly in countries and territories with lower levels of development. Future public health interventions should focus on countries and territories with low levels of development by optimizing healthcare resource allocation, improving basic health infrastructure, enhancing health education, and reducing disease burden inequalities. Global collaboration and data sharing are essential to promote a lifecycle management model for CBDs research and treatment, advancing global health development. Funding This study was supported by the 10.13039/501100001809National Natural Science Foundation of China (No. 82270310) and the 10.13039/501100013058Jiangsu Provincial Key Research and Development Program (No. BE2023662). Research in contextEvidence before this studyPrior research on congenital birth defects (CBDs), particularly focusing on congenital heart defects (CHD), neural tube defects (NTDs), digestive congenital anomalies (DCAs), and Down syndrome (DS), has been limited and lacking in comprehensiveness. To gather existing evidence, we conducted a search of the PubMed database up to September 2024 using the terms “global burden”, “congenital birth defects”, “GBD”, and “DALYs”. This study leverages the latest Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 data to analyze the global, regional, and national burden of CBDs from 1990 to 2021, with an emphasis on health inequalities and changes in disease burden, particularly for these four specific CBDs.Added value of this studyThis is the first study to systematically evaluate the global burden of CHD, NTDs, DCAs, and DS from 1990 to 2021, using GBD 2021 data. It identifies inequalities in the burden of CBDs across different sociodemographic index (SDI) regions, uncovers the driving factors behind changes in disease burden through decomposition analysis, and explores potential improvements through frontier analysis. Additionally, Joinpoint regression analysis was used to identify temporal trends in the burden, and the Bayesian age-period-cohort (BAPC) model was applied to predict future trends up to 2040, further highlighting the urgent need for interventions in low-SDI regions where the burden remains concentrated.Implications of all the available evidenceThis study provides the most up-to-date and comprehensive global assessment of the burden of CHD, NTDs, DCAs, and DS, offering critical insights for clinicians, public health practitioners, and policymakers. The findings emphasize the necessity for targeted public health strategies to address health inequalities, improve resource allocation, and enhance prenatal and postnatal screening and care in low-SDI regions. Additionally, the study calls for strengthened international collaboration to reduce the global burden of congenital anomalies and ensure equitable access to healthcare services for affected populations. INTRODUCTION Congenital birth defects (CBDs) primarily refer to structural abnormalities that arise during embryonic development. These defects are typically detectable before birth and may also be associated with functional impairments. These defects can severely impact physical capabilities, cognitive development, and may even threaten life. The occurrence of congenital birth defects typically results from a complex interplay between genetic factors (such as single-gene mutations and chromosomal abnormalities) and environmental influences (such as maternal nutrition, drug exposure, and infections). Recent studies have also highlighted the critical role of epigenetic regulation in this process, which, by altering gene expression, further increases the risk of these defects.1,2 According to the World Health Organization's 2023 report, approximately 6% of newborns worldwide are affected by congenital birth defects, with about 240,000 newborns dying within 28 days of birth due to these conditions, underscoring their substantial impact on the global disease burden.3,4 Although some research has addressed the global burden of congenital birth defects, these studies often focus on specific periods and regions, lacking a comprehensive analysis of major congenital birth defects, particularly those based on the latest Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 data. The GBD 2021 systematically analyzes and integrates global disease and health data, making it a valuable tool for studying the global, regional, and national burden of CBDs.5 Sociodemographic index (SDI) regions, categorized based on levels of social development, provide a method to detect health inequalities, analyze absolute and relative inequalities, and reveal the temporal impact of socioeconomic development levels on disease burden. Further research, policy-making, international cooperation, and technological improvements can more effectively address the challenges of congenital birth defects and promote global health development.6 This study systematically assessed the burden of CBDs from 1990 to 2021, encompassing all 11 major structural defects as defined in GBD 2021. For a more detailed and focused analysis, we selected four representative types of CBDs—congenital heart defects (CHD), neural tube defects (NTDs), digestive congenital anomalies (DCAs), and Down syndrome (DS)—for secondary, phenotype-specific, and primary analyses. These representative diseases were chosen because of their substantial contribution to the overall burden of congenital birth defects, enabling us to conduct an in-depth study of their trends and determinants. These four defects were selected not only due to their high prevalence and considerable global public health impact but also because they encompass both structural defects and chromosomal abnormalities, offering a comprehensive reflection of the burden of various types of